Brugada syndrome is an inherited disorder that can present with syncope, cardiac arrest, or sudden cardiac death. Multiple genetic mutations have been described that cause this disease. We present a 56-year-old man who sustained an out-of-hospital cardiac arrest, was resuscitated, and was found to have typical features of the Brugada criteria on the electrocardiogram. Genetic testing was positive for a heterozygous mutation in the sodium voltage-gated channel alpha subunit 5 (SCN5A) gene with a p. Leu227Pro (L227P) variant located on exon 6. To our knowledge, this is the first described case with this variant causing malignant arrhythmia with a cardiac arrest. D escribed initially in 1992, Brugada syndrome has an incidence of 0.05% to 0.60% ( 1, 2 ) . Occurring most frequently in Asians, it is also observed in Caucasians, African Americans, and Hispanics. Th e syndrome is characterized by typical electrocardiogram characteristics consisting of right bundle branch block and ST segment elevations in leads V1 to V3. Brugada syndrome is inherited in an autosomal dominant pattern. Multiple genetic mutations have been described.
CASE PRESENTATION
A 56-year-old man sustained an out-of-hospital cardiac arrest. Shortly after he went to bed, his wife noticed he was having labored respirations. Since the family could not wake him, they initiated cardiopulmonary resuscitation and called emergency medical services. Th e patient was found to be in ventricular fi brillation; he was cardioverted and transferred to the University Medical Center with cardiopulmonary resuscitation in progress. On arrival, he was resuscitated, intubated, and mechanically ventilated. He was transferred to the medical intensive care unit, and a hypothermia protocol was initiated. Prior to this event, the patient did not have any syncope or presyncopal episodes and was not taking any medications. He was adopted and did not know any medical history from his father's side.
Th e fi rst electrocardiogram (ECG) obtained following resuscitation demonstrated fi rst-degree atrioventricular block with suspicious coving of the ST segment in lead V2 (Figure 1 ) . Left heart catheterization revealed no evidence of coronary heart disease. Cardiac magnetic resonance imaging was negative for 
A variant of Brugada syndrome
Maryna Popp Switzer , DO, Mohamed Teleb , MD, Enoch Agunanne , MD, and Aamer Abbas, MD contractile abnormalities of the left ventricle, and there was no evidence of noncompacted myocardium or trabeculation. A repeat ECG was obtained during the hospitalization revealing coving of the ST segment in V1 and V2 consistent with the Brugada criteria (Figure 2) . Th e patient made an excellent recovery with a return to normal neurological function. An implantable cardioverter defi brillator was placed prior to his discharge from the hospital. When genetic testing was obtained, a heterozygous mutation was found in the SCN5A gene with a L227P variant located on exon 6.
DISCUSSION
Th e Brugada syndrome is an inherited arrhythmogenic disorder. Individuals with Brugada syndrome are at a higher risk of arrhythmia, such as ventricular tachycardia or ventricular fi brillation, and of sudden cardiac death. Th e average age of presentation is 41 ± 15 years ( 3 ). Men are much more frequently aff ected than women, with a 9:1 ratio. Men are also more likely to be symptomatic, presenting with cardiac events such as syncope or cardiac arrest, and generally tend to have a worse prognosis ( 1, 4 ). To diagnose Brugada syndrome, typical ECG fi ndings need to be present, along with one of the following: a personal history of ventricular tachycardia or ventricular fi brillation, the presence of ventricular tachycardia or ventricular fi brillation during an electrophysiological study, a family history of sudden cardiac death or a coved-type ECG, or agonal breathing during sleep. Th ree types of ECG abnormalities have been described:
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• Type 1 consists of coved-type ST segment elevation of ≥2 mm followed by a negative T wave.
• Type 2 is a saddle-back-type ST segment elevation of ≥2 mm that gradually decreases and is followed by a positive or biphasic T wave. • Type 3 is an ST segment elevation <2 mm that does not meet criteria for type 1 or 2 ( 3 ). Several genetic mutations are responsible for the regulation of diff erent myocardium channels such as sodium, potassium, and calcium. Th ese mutations include but are not limited to the SCN5A, GPD1-L, CACNA1C, CACNB2, SCN1B, KCNE3, SCN3B, and HCN4 genes ( 5 ). Th ere are nearly 300 mutations associated with the gene SCN5A responsible for the sodium channel in the myocardium ( 6, 7 ) . Th ese mutations have been described in chromosome 3p21-24 ( 1 ). In a clinical analysis that evaluated 150 probands in patients with Brugada syndrome compared with >200 control subjects, wild-type (WT) SCN10A with WT-SCN5A in human embryonic kidney cells caused more arrhythmia eff ect, including PR interval prolongation ( 2 ) . Since the discovery of Brugada syndrome, SCN5A has represented about 15% to 30% of all diagnosed cases, making it the most common genotype. A loss of function mutation of SCN5A leads to reduced sodium current available for exchange with the plasma membrane or actual alternation in channel properties. On the other hand, a gain of function leads to arrhythmia syndromes such as prolonged QT.
It is important to recognize that since 2004, more genetics analysis research has discovered the presence of rare missense SCN5A variants in 2% of healthy white subjects and 5% of healthy nonwhite subjects. Th is discovery is important for diff erentiating between the rare harmless mutations and the pathological ones. Multinational analysis evaluated 2111 patients referred for genetic testing for possible diagnosis of Brugada syndrome and involved 27 translated exons present in the SCN5A gene. Th e statistical analysis revealed four common mutations-E1784K, F861WfsX90, D356N, and G1408R-most of which were found to be missense mutations, with the rest involving radical mutations such as frame shift. Eighteen patients had mutations on exon 6, of which 13 were missense mutations, 4 nonsense, and 1 frame shift; none had the L227P variant ( 8 ) . It is important to evaluate more variants to identify the pathological ones requiring early screening to prevent complications. As reported in our patient, the heterozygous mutation in the SCN5A gene with the L227P variant located on exon 6 seems to be the fi rst reported in the literature causing arrhythmia and cardiac arrest.
